NOT-AI-00-004: POLICY ON SUPPORT OF LARGE-SCALE GENOME SEQUENCING PROJECTS – ADDENDUM FOR POTENTIAL BIOTERRORISM AGENTS

Department of Health
and Human Services (HHS)

NIH... Turning Discovery Into Health^®



POLICY ON SUPPORT OF LARGE-SCALE GENOME SEQUENCING PROJECTS   ADDENDUM FOR 
POTENTIAL BIOTERRORISM AGENTS

Release Date:  March 7, 2000

NOTICE:  AI-00-004

National Institute of Allergy and Infectious Diseases
Defense Advanced Research Projects Agency

On September 27, 1999, the National Institute of Allergy and Infectious 
Diseases (NIAID) announced a new policy on support of genome sequencing 
projects, see 
http://grants.nih.gov/grants/guide/notice-files/not99-148.html.  
Detailed information on the NIAID genome sequencing program 
can be found at http://www.niaid.nih.gov/dmid/genomes/.

This addendum announces an opportunity for support of large-scale 
projects for sequencing of high priority pathogens as potential agents 
for bioterrorism.  Except for the addition of these priority pathogens 
and an added receipt date for applications, all provisions of policy 
notice of September 27, 1999 are still applicable.

The National Institute of Allergy and Infectious Diseases (NIAID) with 
funds provided by the Defense Advanced Research Projects Agency (DARPA) 
will accept and consider for funding, under the conditions presented 
below, research applications for large-scale genome sequencing of 
microbial pathogens that have the potential to be used as agents of 
bioterrorism.

1. PRIORITY BIOTERRORISM AGENTS. The priority organisms covered by this 
addendum are listed at: 
http://www.niaid.nih.gov/dmid/genomes/priorities.htm.

2. ADDED APPLICATION RECEIPT DATE.  Applications for sequencing of 
priority bioterrorism pathogens must be submitted for the receipt on 
April 18, 2000 to enable funding by September 2000.

INQUIRIES

Inquiries concerning this policy are encouraged. The 
opportunity to clarify any issues or questions from 
potential applicants is welcome.

Direct inquiries to:

Dr. Michael Gottlieb
Division of Microbiology and Infectious Diseases
National Institute of Allergy and Infectious Diseases
Room 3102
6700-B Rockledge Drive   MSC 7630
Bethesda, MD  20892-7630
Telephone:  301.496.2544
FAX:  301.402.0659
E-mail:    [email protected]

Dr. Eric Eisenstadt
DARPA/DSO
3701 Fairfax Drive
Arlington, VA 22203-1714
Telephone:  703.696.2322 
Fax:   703.696.3999
E-mail: [email protected]

Weekly TOC for this Announcement
NIH Funding Opportunities and Notices